NHS to roll-out new vaccine to tackle bronchiolitis-causing winter cough virus ... trends now
NHS to roll-out new vaccine to tackle bronchiolitis-causing winter cough virus ... trends now
NHS to roll-out breakthrough vaccine to tackle bronchiolitis-causing winter cough virus which puts 29,000 children and 18,000 adults in hospital each year Scientists said Britons will get new vaccine for respiratory syncytial virus (RSV) NHS data will identify those who can most benefit from the new Moderna jab Results show RSV jab 84% effective at preventing cough and fever in the elderly
View
comments
Children and vulnerable adults could soon receive a breakthrough vaccine to protect them from one of the most common winter bugs.
In a media briefing on Friday, scientists announced the first step in vaccinating eligible Britons against respiratory syncytial virus (RSV), best known for causing lung problem bronchiolitis in youngsters.
Researchers will use NHS data to identify those who would best benefit from the jab, as part of a Government-funded project. These patients will then be recommended to receive the vaccine.
It comes a week after trials by drug firm Moderna showed its RSV jab was 84 per cent
